1 / 19

GCP & ETHICS COMMITTEES

GCP & ETHICS COMMITTEES. Ravi Rengachari Vector Control Research Centre PONDICHERRY. If you are a member of an Ethics Committee………………….

Download Presentation

GCP & ETHICS COMMITTEES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY

  2. If you are a member of an Ethics Committee…………………. Determining what is ethical goes beyond merely following prescriptions and requires moral reasoning: consideration of all relevant aspects of the case in its context, weighing and balancing competing moral requirements, and developing justifiable conclusions. Benatar & Singer, BMJ, 321, 30Sep 2000

  3. COMPOSITION OF THE IEC (ICMR Guidelines 2000) • Multi-disciplinary, multi-sectoral • Minimum 5 members, preferably not more than 12-15, ( Balanced age & gender distribution) • Quorum of 5 at least (? 50%) • Chairperson from outside the Institute • Member Secretary from within

  4. COMPOSITION OF THE IEC (ICMR Guidelines 2000) • Suggested mix: Basic medical scientists, clinicians, legal expert, social scientist/ NGO rep, philosopher/ethicist/theologian, Lay member • Additional members co-opted as per need ( specialists, specific communities, patient groups etc)

  5. Appointment • Authority by which appointed • Membership requirements • Terms of Reference • Conditions of appointment

  6. Responsibilities of an IEC • To protect the dignity, rights and well being of potential research participants • To ensure that universal ethical values and international scientific standards are expressed in terms of local community values and customs • To assist in the development and education of a research community responsive to local health care requirements

  7. An IEC should demonstrate • Competence • Efficiency • Independence ( from political, institutional, professional & market influences) • Consistency

  8. REVIEW PROCEDURESMandate • Review new proposals • Risk / benefit assessment • Consent procedures, confidentiality, justice issues to be looked into • Evaluate progress of ongoing studies ( annual, more frequently if required); (see that no harm is caused to research subjects) • Assess Final Reports ( look at post-trial benefit issues, commercialisation etc) NOTE: IEC should have SOPs for each of the above ? Multi-centre Trials

  9. BASIC ETHICAL REVIEW PROCEDURES • Scientific review must be done before ethical review • All biomedical research proposals involving human subjects must be reviewed and cleared by an appropriately constituted IEC or IRB, before initiating the studies • Review only in formal meetings and not through circulation • IEC should also continuously monitor the study to ensure that ethical guidelines are followed

  10. REVIEW PROCEDURES • Submission of Application (?Deadlines) • Decision making process • Interim Review • Record Keeping • Special Considerations

  11. REVIEW PROCEDURES What to look for in an Application • ?Format • Project protocol in full ( justification for study, objectives, methods, I/E criteria, recruitment procedures, statistical considerations, Consent Forms/procedures, Safety information on interventions to be used) • CV of investigator(s); Institutional facilities • Source of funding for study; agreements relating to publication of results • Confidentiality procedures

  12. REVIEW PROCEDURES What to look for in an Application • Data Handling Procedures • Procedures for handling adverse events • Proposed arrangements for compensation/ reimbursements • Clearances from Regulatory Authorities • Willingness to comply with national/international GCP protocols • Statement on probable ethical issues, and how these will be addressed

  13. REVIEW PROCEDURESDecision making process • Decision by consensus, to be communicated in writing, and in detail • Conflicts of interest to be addressed, if any • Reasons for decision to be recorded • Reversing a decision or discontinuing a trial possible, if good & sufficient reasons exist. • Consider any amendments to protocol, adverse events, new information likely to influence study etc

  14. REVIEW PROCEDURESDecision making process • Investigator &/or patient /interested parties may be asked for inputs • Subject experts may be invited, and opinions recorded. • Decisions to be taken only in the absence of non-members. • Minutes

  15. REVIEW PROCEDURESInterim Review How & When? • Each IEC to decide for itself, the procedure & mechanism Why? • To re-examine a proposal • To check if there is any valid scientific or ethical reason to suspend or terminate a study • Expedited Review

  16. REVIEW PROCEDURESRecord Keeping Documents to be dated, filed & preserved • Constitution & composition of the IEC • CVs of all members • SOPs of the IEC • National & International Guidelines • Copies of protocols submitted to IEC • All correspondence with IEC members & investigators reg: application, decision and follow-up • Agenda of all IEC meetings

  17. REVIEW PROCEDURESRecord Keeping • Minutes of all IEC Meetings with Chairperson’s signature • Copies of decisions communicated to applicants • Record of notifications issued for premature termination of a study with reasons • Final Reports of studies with microfilms,CDs and video recordings. • Records to be maintained for at least 15 years ( if not permanently), after completion/termination of study.

  18. REVIEW PROCEDURESSPECIAL CONSIDERATIONS • Research involving children, pregnant & lactating women • Vulnerable subjects • Those with diminished autonomy • Commercialisation of research • International collaboration

  19. Thank You

More Related